Any drug which causes the onset of an allergic reaction.
| Member | Definition | Class |
|---|
| 1,2-benzisothiazoline-3-one | An organic heterobicyclic compound based on a fused 1,2-thiazole and benzene bicyclic ring skeleton, with the S atom positioned adjacent to one of the positions of ring fusion. | benzo[d]isothiazol-3-one |
| 10-hydroxycarbamazepine | A dibenzoazepine that is 5H-dibenzo[b,f]azepine, reduced across the C-10,11 positions and carrying a carbamoyl substituent at the azepine nitrogen and a hydroxy function at C-10. A voltage-gated sodium channel blocker with anticonvulsant and mood-stabilizing effects, it is related to oxcarbazepine and is an active metabolite of oxcarbazepine. | licarbazepine |
| 3,3',4',5-tetrachlorosalicylanilide | A salicylanilide derivative with chloride substituents at C-3 and C-5 of the salicylate moiety and at C-3 and C-4 of the anilide moiety. | 3,3',4',5-tetrachlorosalicylanilide |
| abacavir | A 2,6-diaminopurine that is (1S)-cyclopent-2-en-1-ylmethanol in which the pro-R hydrogen at the 4-position is substituted by a 2-amino-6-(cyclopropylamino)-9H-purin-9-yl group. A nucleoside analogue reverse transcriptase inhibitor (NRTI) with antiretroviral activity against HIV, it is used (particularly as the sulfate) with other antiretrovirals in combination therapy of HIV infection. | abacavir |
| alclofenac | An aromatic ether in which the ether oxygen links an allyl group to the 4-position of (3-chlorophenyl)acetic acid.A non-steroidal anti-inflammatory drug, it was withdrawn from the UK market in 1979 due to concerns with its association with vasculitis and rash. | alclofenac |
| amodiaquine | A quinoline having a chloro group at the 7-position and an aryl amino group at the 4-position. | amodiaquine |
| aspirin | A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity. | acetylsalicylic acid |
| aztreonam | A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking. | aztreonam |
| barbital | A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by two ethyl groups. Formerly used as a hypnotic (sleeping aid). | 5,5-diethylbarbituric acid |
| benoxinate | A benzoate ester in which 4-amino-3-butoxybenzoic acid and 2-(diethylamino)ethanol have combined to form the ester bond; an ester-based local anaesthetic (ester "caine") used especially in ophthalmology and otolaryngology. | oxybuprocaine |
| benzoic acid | A compound comprising a benzene ring core carrying a carboxylic acid substituent. | benzoic acid |
| calcipotriene | A seco-cholestane that is 26,27-cyclo-9,10-secocholesta-5,7,10,22-tetraene carrying additional hydroxy substituents at positions 1, 3 and 24. It is used (as its hydrate) in combination with betamethasone dipropionate, a corticosteroid, for the topical treatment of plaque psoriasis in adult patients. | calcipotriol |
| carbamazepine | A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant. | carbamazepine |
| cefaclor anhydrous | A cephalosporin bearing chloro and (R)-2-amino-2-phenylacetamido groups at positions 3 and 7, respectively, of the cephem skeleton. | cefaclor |
| cefixime | A third-generation cephalosporin antibiotic bearing vinyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. It is used in the treatment of gonorrhoea, tonsilitis, pharyngitis, bronchitis, and urinary tract infections. | cefixime |
| cefotaxime | A cephalosporin compound having acetoxymethyl and [2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino side groups. | cefotaxime |
| ceftazidime | A third-generation cephalosporin antibiotic bearing pyridinium-1-ylmethyl and {[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. | ceftazidime |
| ceftriaxone | A third-generation cephalosporin compound having 2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetylamino and [(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl side-groups. | ceftriaxone |
| cefuroxime | A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain. | cefuroxime |
| chlorambucil | A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia. | chlorambucil |
| codeine | A morphinane alkaloid found in the opium poppy, Papaver somniferum var. album; has analgesic, anti-tussive and anti-diarrhoeal properties. | codeine |
| cromolyn sodium | An organic sodium salt that is the disodium salt of cromoglycic acid. | disodium cromoglycate |
| desipramine | A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group. | desipramine |
| desipramine hydrochloride | The hydrochloride salt of desipramine. | desipramine hydrochloride |
| diaveridine | An aminopyrimidine in which the pyrimidine ring carries amino substituents at C-2 and C-4 and a 3,4-dimethoxybenzyl group at C-5. A folic acid antagonist, it is used as a synergist with sulfonamides against the parasitic Eimeria species. | diaveridine |
| diclofenac | A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position. | diclofenac |
| diphenylcyclopropenone | A cyclopropenone compound having phenyl substituents at the 2- and 3-positions. | diphenylcyclopropenone |
| eslicarbazepine acetate | The acetate ester, with S configuration, of licarbazepine. An anticonvulsant, it is approved for use in Europe and the United States as an adjunctive therapy for epilepsy. | eslicarbazepine acetate |
| fenoprofen | A monocarboxylic acid that is propanoic acid in which one of the hydrogens at position 2 is substituted by a 3-phenoxyphenyl group. A non-steroidal anti-inflammatory drug, the dihydrate form of the calcium salt is used for the management of mild to moderate pain and for the relief of pain and inflammation associated with disorders such as arthritis. It is pharmacologically similar to aspirin, but causes less gastrointestinal bleeding. | fenoprofen |
| fentichlor | An aryl sulfide having two 5-chloro-2-hydroxyphenyl groups attached to sulfur; an antiinfective drug mostly used in veterinary medicine. | fenticlor |
| hydrocortisone-17-butyrate | Cortisol esterified with butyric acid at the 17-hydroxy group. | cortisol 17-butyrate |
| ibuprofen | A monocarboxylic acid that is propionic acid in which one of the hydrogens at position 2 is substituted by a 4-(2-methylpropyl)phenyl group. | ibuprofen |
| isoniazid | A carbohydrazide obtained by formal condensation between pyridine-4-carboxylic acid and hydrazine. | isoniazide |
| ketoprofen | An oxo monocarboxylic acid that consists of propionic acid substituted by a 3-benzoylphenyl group at position 2. | ketoprofen |
| lidocaine | The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline. | lidocaine |
| melphalan | A phenylalanine derivative comprising L-phenylalanine having [bis(2-chloroethyl)amino group at the 4-position on the phenyl ring. | melphalan |
| mepivacaine | A piperidinecarboxamide in which N-methylpipecolic acid and 2,6-dimethylaniline have combined to form the amide bond. It is used as a local amide-type anaesthetic. | mepivacaine |
| meropenem | A carbapenemcarboxylic acid in which the azetidine and pyrroline rings carry 1-hydroxymethyl and in which the azetidine and pyrroline rings carry 1-hydroxymethyl and 5-(dimethylcarbamoyl)pyrrolidin-3-ylthio substituents respectively. | meropenem |
| methohexital | A barbiturate, the structure of which is that of barbituric acid substituted at N-1 by a methyl group and at C-5 by allyl and 1-methylpent-2-ynyl groups. | methohexital |
| metiazinic acid | Phenothiazine substituted at nitrogen by a methyl group and at C-2 by a carboxymethyl group. | metiazinic acid |
| morphine | A morphinane alkaloid that is a highly potent opiate analgesic psychoactive drug. Morphine acts directly on the central nervous system (CNS) to relieve pain but has a high potential for addiction, with tolerance and both physical and psychological dependence developing rapidly. Morphine is the most abundant opiate found in Papaver somniferum (the opium poppy). | morphine |
| naproxen | A methoxynaphthalene that is 2-methoxynaphthalene substituted by a carboxy ethyl group at position 6. Naproxen is a non-steroidal anti-inflammatory drug commonly used for the reduction of pain, fever, inflammation and stiffness caused by conditions such as osteoarthritis, kidney stones, rheumatoid arthritis, psoriatic arthritis, gout, ankylosing spondylitis, menstrual cramps, tendinitis, bursitis, and for the treatment of primary dysmenorrhea. It works by inhibiting both the COX-1 and COX-2 enzymes. | naproxen |
| oxcarbazepine | A dibenzoazepine derivative, having a carbamoyl group at the ring nitrogen, substituted with an oxo group at C-4 of the azepeine ring which is also hydrogenated at C-4 and C-5. It is a anticholinergic anticonvulsant and mood stabilizing drug, used primarily in the treatment of epilepsy. | oxcarbazepine |
| parthenolide | A sesquiterpene lactone and active principle of Feverfew (Tanacetum parthenium). | parthenolide |
| penicillamine | An optically active form of penicillamine having D-configuration. Pharmaceutical form (L-form is toxic) of chelating agent used to treat heavy metal poisoning. | D-penicillamine |
| penicillin g | A penicillin in which the substituent at position 6 of the penam ring is a phenylacetamido group. | benzylpenicillin |
| perfosfamide | A phosphorodiamide that is the active metabolite of the nitrogen mustard cyclophosphamide. It has potent antineoplastic and immunosuppressive properties. | 4-hydroperoxycyclophosphamide |
| phenobarbital | A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and phenyl groups. | phenobarbital |
| phenytoin | A imidazolidine-2,4-dione that consists of hydantoin bearing two phenyl substituents at position 5. | phenytoin |
| pholcodine | A morphinane alkaloid that is a derivative of morphine with a 2-morpholinoethyl group at the 3-position. | pholcodine |
| procaine | A benzoate ester, formally the result of esterification of 4-aminobenzoic acid with 2-diethylaminoethanol but formed experimentally by reaction of ethyl 4-aminobenzoate with 2-diethylaminoethanol. | procaine |
| pulmicort | A glucocorticoid steroid having a highly oxygenated pregna-1,4-diene structure. It is used mainly in the treatment of asthma and non-infectious rhinitis and for treatment and prevention of nasal polyposis. | budesonide |
| quinidine | A cinchona alkaloid consisting of cinchonine with the hydrogen at the 6-position of the quinoline ring substituted by methoxy. | quinidine |
| ranitidine | A member of the class of furans used to treat peptic ulcer disease (PUD) and gastroesophageal reflux disease. | ranitidine |
| ranitidine hydrochloride | | ranitidine hydrochloride |
| rocuronium | A 5alpha-androstane compound having 3alpha-hydroxy-, 17beta-acetoxy-, 2beta-morpholino- and 16beta-N-allyllyrrolidinium substituents. | rocuronium |
| sodium benzoate | An organic sodium salt resulting from the replacement of the proton from the carboxy group of benzoic acid by a sodium ion. | sodium benzoate |
| succinylcholine | A quaternary ammonium ion that is the bis-choline ester of succinic acid. | succinylcholine |
| sulfachlorpyridazine | A sulfonamide antimicrobial used for urinary tract infections and in veterinary medicine. | sulfachloropyridazine |
| sulfadiazine | A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position. | sulfadiazine |
| sulfadimethoxine | A sulfonamide consisting of pyrimidine having methoxy substituents at the 2- and 6-positions and a 4-aminobenzenesulfonamido group at the 4-position. | sulfadimethoxine |
| sulfamerazine | A sulfonamide consisting of pyrimidine with a methyl substituent at the 4-position and a 4-aminobenzenesulfonamido group at the 2-position. | sulfamerazine |
| sulfamethazine | A sulfonamide consisting of pyrimidine with methyl substituents at the 4- and 6-positions and a 4-aminobenzenesulfonamido group at the 2-position. | sulfamethazine |
| sulfamethizole | A sulfonamide consisting of a 1,3,4-thiadiazole nucleus with a methyl substituent at C-5 and a 4-aminobenzenesulfonamido group at C-2. | sulfamethizole |
| sulfamethoxazole | An isoxazole (1,2-oxazole) compound having a methyl substituent at the 5-position and a 4-aminobenzenesulfonamido group at the 3-position. | sulfamethoxazole |
| sulfamethoxypyridazine | A sulfonamide consisting of pyridazine having a methoxy substituent at the 6-position and a 4-aminobenzenesulfonamido group at the 3-position. | sulfamethoxypyridazine |
| sulfamoxole | A sulfonamide antibiotic in which 4-aminobenzenesulfonic acid and 4,5-dimethyl-1,3-oxazol-2-amine have combined to form the sulfonamide bond. | sulfamoxole |
| sulfanilamide | A sulfonamide in which the sulfamoyl functional group is attached to aniline at the 4-position. | sulfanilamide |
| sulfapyridine | A sulfonamide consisting of pyridine with a 4-aminobenzenesulfonamido group at the 2-position. | sulfapyridine |
| sulfathiazole | A 1,3-thiazole compound having a 4-aminobenzenesulfonamido group at the 2-position. | sulfathiazole |
| sulfisoxazole | A sulfonamide antibacterial with an oxazole substituent. It has antibiotic activity against a wide range of gram-negative and gram-positive organisms. | sulfisoxazole |
| suprofen | An aromatic ketone that is thiophene substituted at C-2 by a 4-(1-carboxyethyl)benzoyl group. | suprofen |
| thimerosal | An alkylmercury compound (approximately 49% mercury by weight) used as an antiseptic and antifungal agent. | thimerosal |
| thiopental | A barbiturate, the structure of which is that of 2-thiobarbituric acid substituted at C-5 by ethyl and sec-pentyl groups. | thiopental |
| tiaprofenic acid | An aromatic ketone that is thiophene substituted at C-2 by benzoyl and at C-4 by a 1-carboxyethyl group. | tiaprofenic acid |
| triclosan | An aromatic ether that is phenol which is substituted at C-5 by a chloro group and at C-2 by a 2,4-dichlorophenoxy group. It is widely used as a preservative and antimicrobial agent in personal care products such as soaps, skin creams, toothpaste and deodorants as well as in household items such as plastic chopping boards, sports equipment and shoes. | triclosan |
| trimethoprim | An aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge. | trimethoprim |
| tubocurarine | A benzylisoquinoline alkaloid muscle relaxant which constitutes the active component of curare. | tubocurarine |
| vecuronium | A 5alpha-androstane compound having 3alpha-acetoxy-, 17beta-acetoxy-, 2beta-piperidino- and 16beta-N-methylpiperidinium substituents. | vecuronium |
| Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
|---|
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | Homo sapiens (human) | Potency | 20.5651 | 1 | 10 |
| 15-lipoxygenase, partial | Homo sapiens (human) | Potency | 12.2876 | 1 | 3 |
| 67.9K protein | Vaccinia virus | Potency | 15.2617 | 2 | 10 |
| acetylcholinesterase | Homo sapiens (human) | Potency | 32.0386 | 3 | 20 |
| activating transcription factor 6 | Homo sapiens (human) | Potency | 31.4435 | 2 | 21 |
| aldehyde dehydrogenase 1 family, member A1 | Homo sapiens (human) | Potency | 21.1927 | 1 | 22 |
| Alpha-synuclein | Homo sapiens (human) | Potency | 8.1725 | 1 | 3 |
| apical membrane antigen 1, AMA1 | Plasmodium falciparum 3D7 | Potency | 14.1254 | 1 | 1 |
| AR protein | Homo sapiens (human) | Potency | 16.6528 | 12 | 167 |
| aryl hydrocarbon receptor | Homo sapiens (human) | Potency | 22.0021 | 3 | 23 |
| arylsulfatase A | Homo sapiens (human) | Potency | 7.6156 | 1 | 4 |
| ATAD5 protein, partial | Homo sapiens (human) | Potency | 22.0971 | 3 | 6 |
| Ataxin-2 | Homo sapiens (human) | Potency | 19.5944 | 2 | 12 |
| ATP-dependent phosphofructokinase | Trypanosoma brucei brucei TREU927 | Potency | 17.8576 | 5 | 11 |
| ATPase family AAA domain-containing protein 5 | Homo sapiens (human) | Potency | 23.2146 | 2 | 17 |
| atrial natriuretic peptide receptor 1 precursor | Homo sapiens (human) | Potency | 8.4921 | 1 | 1 |
| atrial natriuretic peptide receptor 2 precursor | Homo sapiens (human) | Potency | 16.4816 | 1 | 1 |
| Bloom syndrome protein isoform 1 | Homo sapiens (human) | Potency | 2.4935 | 2 | 11 |
| BRCA1 | Homo sapiens (human) | Potency | 14.1254 | 1 | 1 |
| bromodomain adjacent to zinc finger domain 2B | Homo sapiens (human) | Potency | 52.8223 | 1 | 6 |
| caspase 7, apoptosis-related cysteine protease | Homo sapiens (human) | Potency | 43.7764 | 1 | 8 |
| caspase-3 | Cricetulus griseus (Chinese hamster) | Potency | 36.4626 | 1 | 3 |
| caspase-3 | Homo sapiens (human) | Potency | 43.7764 | 1 | 8 |
| Caspase-7 | Cricetulus griseus (Chinese hamster) | Potency | 36.4626 | 1 | 3 |
| Cellular tumor antigen p53 | Homo sapiens (human) | Potency | 28.9957 | 3 | 44 |
| cellular tumor antigen p53 isoform a | Homo sapiens (human) | Potency | 1.1294 | 2 | 2 |
| Chain A, 2-oxoglutarate Oxygenase | Homo sapiens (human) | Potency | 28.4258 | 1 | 13 |
| Chain A, Beta-lactamase | Escherichia coli K-12 | Potency | 29.3280 | 2 | 13 |
| Chain A, Cruzipain | Trypanosoma cruzi | Potency | 17.7548 | 2 | 4 |
| Chain A, Ferritin light chain | Equus caballus (horse) | Potency | 21.7156 | 1 | 4 |
| Chain A, HADH2 protein | Homo sapiens (human) | Potency | 17.7383 | 2 | 9 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | Homo sapiens (human) | Potency | 22.4520 | 1 | 5 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | Homo sapiens (human) | Potency | 179.0712 | 1 | 9 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | Giardia intestinalis | Potency | 14.4268 | 1 | 7 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | Homo sapiens (human) | Potency | 25.5105 | 1 | 8 |
| Chain B, HADH2 protein | Homo sapiens (human) | Potency | 17.7383 | 2 | 9 |
| chromobox protein homolog 1 | Homo sapiens (human) | Potency | 67.8217 | 2 | 18 |
| cytochrome P450 2C19 precursor | Homo sapiens (human) | Potency | 17.9414 | 1 | 5 |
| cytochrome P450 2C9 precursor | Homo sapiens (human) | Potency | 18.0049 | 1 | 5 |
| cytochrome P450 2C9, partial | Homo sapiens (human) | Potency | 14.6506 | 1 | 17 |
| cytochrome P450 2D6 | Homo sapiens (human) | Potency | 12.6312 | 1 | 15 |
| cytochrome P450 2D6 isoform 1 | Homo sapiens (human) | Potency | 14.4246 | 1 | 7 |
| cytochrome P450 3A4 isoform 1 | Homo sapiens (human) | Potency | 20.6785 | 2 | 35 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | Homo sapiens (human) | Potency | 16.6363 | 2 | 25 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | Homo sapiens (human) | Potency | 18.9506 | 1 | 21 |
| D(1A) dopamine receptor | Homo sapiens (human) | Potency | 5.2914 | 2 | 3 |
| D(1A) dopamine receptor | Sus scrofa (pig) | Potency | 14.6892 | 1 | 1 |
| Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) | Potency | 10.0000 | 1 | 1 |
| DNA polymerase eta isoform 1 | Homo sapiens (human) | Potency | 26.5602 | 2 | 4 |
| DNA polymerase iota isoform a (long) | Homo sapiens (human) | Potency | 50.1405 | 2 | 11 |
| DNA polymerase kappa isoform 1 | Homo sapiens (human) | Potency | 40.2568 | 2 | 8 |
| dopamine D1 receptor | Homo sapiens (human) | Potency | 0.0231 | 1 | 1 |
| endonuclease IV | Escherichia coli | Potency | 4.4173 | 1 | 2 |
| estrogen nuclear receptor alpha | Homo sapiens (human) | Potency | 24.7683 | 12 | 171 |
| estrogen receptor 2 (ER beta) | Homo sapiens (human) | Potency | 30.8524 | 3 | 24 |
| estrogen-related nuclear receptor alpha | Homo sapiens (human) | Potency | 25.8280 | 10 | 131 |
| euchromatic histone-lysine N-methyltransferase 2 | Homo sapiens (human) | Potency | 19.3261 | 1 | 36 |
| EWS/FLI fusion protein | Homo sapiens (human) | Potency | 13.7354 | 4 | 23 |
| farnesoid X nuclear receptor | Homo sapiens (human) | Potency | 27.4617 | 5 | 29 |
| flap endonuclease 1 | Homo sapiens (human) | Potency | 43.6232 | 1 | 5 |
| Fumarate hydratase | Homo sapiens (human) | Potency | 25.3885 | 1 | 8 |
| G | Vesicular stomatitis virus | Potency | 14.6506 | 1 | 17 |
| GABA theta subunit | Rattus norvegicus (Norway rat) | Potency | 20.8420 | 1 | 19 |
| GALC protein | Homo sapiens (human) | Potency | 0.7079 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | Potency | 20.8420 | 1 | 19 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | Potency | 20.8420 | 1 | 19 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | Potency | 20.8420 | 1 | 19 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | Potency | 20.8420 | 1 | 19 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Rattus norvegicus (Norway rat) | Potency | 20.8420 | 1 | 19 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Rattus norvegicus (Norway rat) | Potency | 20.8420 | 1 | 19 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Rattus norvegicus (Norway rat) | Potency | 20.8420 | 1 | 19 |
| Gamma-aminobutyric acid receptor subunit beta-2 | Rattus norvegicus (Norway rat) | Potency | 20.8420 | 1 | 19 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Rattus norvegicus (Norway rat) | Potency | 20.8420 | 1 | 19 |
| Gamma-aminobutyric acid receptor subunit delta | Rattus norvegicus (Norway rat) | Potency | 20.8420 | 1 | 19 |
| Gamma-aminobutyric acid receptor subunit epsilon | Rattus norvegicus (Norway rat) | Potency | 20.8420 | 1 | 19 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Rattus norvegicus (Norway rat) | Potency | 20.8420 | 1 | 19 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Rattus norvegicus (Norway rat) | Potency | 20.8420 | 1 | 19 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Rattus norvegicus (Norway rat) | Potency | 20.8420 | 1 | 19 |
| Gamma-aminobutyric acid receptor subunit pi | Rattus norvegicus (Norway rat) | Potency | 20.8420 | 1 | 19 |
| geminin | Homo sapiens (human) | Potency | 13.0250 | 3 | 53 |
| GLI family zinc finger 3 | Homo sapiens (human) | Potency | 18.7006 | 3 | 58 |
| glp-1 receptor, partial | Homo sapiens (human) | Potency | 12.6713 | 1 | 11 |
| GLS protein | Homo sapiens (human) | Potency | 19.6209 | 2 | 19 |
| glucocerebrosidase | Homo sapiens (human) | Potency | 23.1414 | 1 | 4 |
| glucocorticoid receptor [Homo sapiens] | Homo sapiens (human) | Potency | 16.0137 | 5 | 49 |
| Glutamate receptor 2 | Rattus norvegicus (Norway rat) | Potency | 25.8678 | 1 | 15 |
| Glycoprotein hormones alpha chain | Homo sapiens (human) | Potency | 5.9976 | 1 | 2 |
| GTP-binding nuclear protein Ran isoform 1 | Homo sapiens (human) | Potency | 11.4366 | 1 | 2 |
| Guanine nucleotide-binding protein G | Homo sapiens (human) | Potency | 31.6354 | 2 | 3 |
| heat shock protein beta-1 | Homo sapiens (human) | Potency | 28.7274 | 2 | 19 |
| Histamine H2 receptor | Cavia porcellus (domestic guinea pig) | Potency | 16.6654 | 2 | 25 |
| histone acetyltransferase KAT2A isoform 1 | Homo sapiens (human) | Potency | 25.2126 | 1 | 9 |
| histone deacetylase 9 isoform 3 | Homo sapiens (human) | Potency | 20.6755 | 2 | 11 |
| Histone H2A.x | Cricetulus griseus (Chinese hamster) | Potency | 44.7578 | 2 | 17 |
| histone-lysine N-methyltransferase 2A isoform 2 precursor | Homo sapiens (human) | Potency | 44.6684 | 1 | 1 |
| HLA class I histocompatibility antigen, B alpha chain | Homo sapiens (human) | Potency | 14.6506 | 1 | 17 |
| huntingtin isoform 2 | Homo sapiens (human) | Potency | 22.5119 | 2 | 6 |
| hypothetical protein, conserved | Trypanosoma brucei | Potency | 22.3208 | 1 | 3 |
| hypoxia-inducible factor 1 alpha subunit | Homo sapiens (human) | Potency | 23.5794 | 2 | 17 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | Homo sapiens (human) | Potency | 12.8296 | 3 | 14 |
| IDH1 | Homo sapiens (human) | Potency | 11.0576 | 1 | 12 |
| importin subunit beta-1 isoform 1 | Homo sapiens (human) | Potency | 63.8651 | 2 | 5 |
| Inositol hexakisphosphate kinase 1 | Homo sapiens (human) | Potency | 14.6506 | 1 | 34 |
| Inositol monophosphatase 1 | Rattus norvegicus (Norway rat) | Potency | 9.2689 | 1 | 3 |
| Integrin alpha-IIb | Homo sapiens (human) | Potency | 1.0000 | 1 | 1 |
| Integrin beta-3 | Homo sapiens (human) | Potency | 1.0000 | 1 | 1 |
| Interferon beta | Homo sapiens (human) | Potency | 15.8198 | 3 | 23 |
| interleukin 8 | Homo sapiens (human) | Potency | 70.9011 | 1 | 8 |
| lamin isoform A-delta10 | Homo sapiens (human) | Potency | 8.9720 | 2 | 22 |
| lethal factor (plasmid) | Bacillus anthracis str. A2012 | Potency | 7.9979 | 1 | 8 |
| lethal(3)malignant brain tumor-like protein 1 isoform I | Homo sapiens (human) | Potency | 31.6228 | 1 | 1 |
| Luciferase | Photinus pyralis (common eastern firefly) | Potency | 22.9844 | 4 | 18 |
| lysosomal alpha-glucosidase preproprotein | Homo sapiens (human) | Potency | 17.7828 | 1 | 1 |
| M-phase phosphoprotein 8 | Homo sapiens (human) | Potency | 89.1251 | 1 | 1 |
| Microtubule-associated protein tau | Homo sapiens (human) | Potency | 24.2289 | 2 | 23 |
| mitogen-activated protein kinase 1 | Homo sapiens (human) | Potency | 13.7110 | 2 | 6 |
| muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | Potency | 14.7670 | 2 | 13 |
| muscleblind-like protein 1 isoform 1 | Homo sapiens (human) | Potency | 50.0500 | 1 | 2 |
| neuropeptide S receptor isoform A | Homo sapiens (human) | Potency | 14.2191 | 1 | 2 |
| NFKB1 protein, partial | Homo sapiens (human) | Potency | 3.3586 | 2 | 12 |
| nonstructural protein 1 | Influenza A virus (A/WSN/1933(H1N1)) | Potency | 6.4006 | 1 | 4 |
| Nrf2 | Homo sapiens (human) | Potency | 13.9281 | 1 | 3 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | Homo sapiens (human) | Potency | 31.9160 | 4 | 44 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | Homo sapiens (human) | Potency | 15.4433 | 2 | 4 |
| nuclear factor NF-kappa-B p105 subunit isoform 1 | Homo sapiens (human) | Potency | 35.4813 | 1 | 1 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | Homo sapiens (human) | Potency | 26.7112 | 2 | 15 |
| Nuclear receptor ROR-gamma | Homo sapiens (human) | Potency | 29.2000 | 1 | 4 |
| nuclear receptor ROR-gamma isoform 1 | Mus musculus (house mouse) | Potency | 9.9876 | 2 | 12 |
| nuclear receptor subfamily 1, group I, member 2 | Rattus norvegicus (Norway rat) | Potency | 10.8631 | 1 | 3 |
| nuclear receptor subfamily 1, group I, member 3 | Homo sapiens (human) | Potency | 25.2192 | 3 | 54 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | Homo sapiens (human) | Potency | 13.1604 | 1 | 7 |
| Parkin | Homo sapiens (human) | Potency | 21.1546 | 1 | 2 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Homo sapiens (human) | Potency | 32.9838 | 1 | 2 |
| peripheral myelin protein 22 | Rattus norvegicus (Norway rat) | Potency | 5.2184 | 2 | 17 |
| peripheral myelin protein 22 isoform 1 | Homo sapiens (human) | Potency | 41.6494 | 1 | 4 |
| peroxisome proliferator activated receptor gamma | Homo sapiens (human) | Potency | 29.3269 | 5 | 38 |
| peroxisome proliferator-activated receptor delta | Homo sapiens (human) | Potency | 22.7263 | 5 | 33 |
| phosphoglycerate kinase | Trypanosoma brucei brucei TREU927 | Potency | 3.4618 | 2 | 2 |
| phosphopantetheinyl transferase | Bacillus subtilis | Potency | 33.2966 | 3 | 13 |
| PINK1 | Homo sapiens (human) | Potency | 21.1546 | 1 | 2 |
| plasminogen precursor | Mus musculus (house mouse) | Potency | 5.6931 | 1 | 9 |
| polyprotein | Zika virus | Potency | 25.3885 | 1 | 8 |
| polyunsaturated fatty acid lipoxygenase ALOX12 | Homo sapiens (human) | Potency | 8.9125 | 1 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | Homo sapiens (human) | Potency | 14.6563 | 1 | 5 |
| potassium voltage-gated channel subfamily H member 2 isoform d | Homo sapiens (human) | Potency | 21.6749 | 1 | 8 |
| PPM1D protein | Homo sapiens (human) | Potency | 14.7403 | 1 | 2 |
| pregnane X nuclear receptor | Homo sapiens (human) | Potency | 32.0945 | 3 | 33 |
| pregnane X receptor | Rattus norvegicus (Norway rat) | Potency | 55.6169 | 1 | 4 |
| progesterone receptor | Homo sapiens (human) | Potency | 14.7182 | 3 | 25 |
| Rap guanine nucleotide exchange factor 3 | Homo sapiens (human) | Potency | 67.4725 | 2 | 3 |
| Rap guanine nucleotide exchange factor 4 | Homo sapiens (human) | Potency | 35.4813 | 1 | 1 |
| RAR-related orphan receptor gamma | Mus musculus (house mouse) | Potency | 18.0855 | 2 | 50 |
| regulator of G-protein signaling 4 | Homo sapiens (human) | Potency | 20.0851 | 1 | 6 |
| relaxin receptor 1 isoform 1 | Homo sapiens (human) | Potency | 12.5893 | 1 | 1 |
| retinoic acid nuclear receptor alpha variant 1 | Homo sapiens (human) | Potency | 27.3401 | 3 | 68 |
| retinoid X nuclear receptor alpha | Homo sapiens (human) | Potency | 15.6444 | 4 | 46 |
| serine/threonine-protein kinase mTOR isoform 1 | Homo sapiens (human) | Potency | 20.4054 | 2 | 2 |
| serine/threonine-protein kinase PLK1 | Homo sapiens (human) | Potency | 17.6059 | 1 | 5 |
| SMAD family member 2 | Homo sapiens (human) | Potency | 26.4645 | 2 | 18 |
| SMAD family member 3 | Homo sapiens (human) | Potency | 26.4645 | 2 | 18 |
| Smad3 | Homo sapiens (human) | Potency | 9.0330 | 1 | 6 |
| snurportin-1 | Homo sapiens (human) | Potency | 63.8651 | 2 | 5 |
| Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | Potency | 22.1446 | 2 | 13 |
| survival motor neuron protein isoform d | Homo sapiens (human) | Potency | 15.3224 | 1 | 10 |
| TAR DNA-binding protein 43 | Homo sapiens (human) | Potency | 20.2655 | 1 | 6 |
| TDP1 protein | Homo sapiens (human) | Potency | 13.8600 | 2 | 59 |
| thioredoxin glutathione reductase | Schistosoma mansoni | Potency | 49.2085 | 1 | 5 |
| thioredoxin reductase | Rattus norvegicus (Norway rat) | Potency | 21.5164 | 3 | 23 |
| Thrombopoietin | Homo sapiens (human) | Potency | 7.5331 | 2 | 6 |
| thyroid hormone receptor beta isoform 2 | Rattus norvegicus (Norway rat) | Potency | 20.5851 | 3 | 49 |
| thyroid hormone receptor beta isoform a | Homo sapiens (human) | Potency | 26.5132 | 2 | 8 |
| thyroid stimulating hormone receptor | Homo sapiens (human) | Potency | 15.9250 | 7 | 46 |
| thyrotropin-releasing hormone receptor | Homo sapiens (human) | Potency | 31.0505 | 2 | 5 |
| transcriptional regulator ERG isoform 3 | Homo sapiens (human) | Potency | 9.2268 | 1 | 4 |
| transient receptor potential cation channel subfamily V member 1 | Homo sapiens (human) | Potency | 17.7828 | 1 | 1 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | Homo sapiens (human) | Potency | 26.6198 | 2 | 2 |
| urokinase plasminogen activator surface receptor precursor | Mus musculus (house mouse) | Potency | 5.6931 | 1 | 9 |
| urokinase-type plasminogen activator precursor | Mus musculus (house mouse) | Potency | 5.6931 | 1 | 9 |
| USP1 protein, partial | Homo sapiens (human) | Potency | 54.7208 | 2 | 13 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | Homo sapiens (human) | Potency | 23.7573 | 2 | 25 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | Homo sapiens (human) | Potency | 19.9663 | 5 | 26 |
| vitamin D3 receptor isoform VDRA | Homo sapiens (human) | Potency | 44.9216 | 1 | 10 |
| Voltage-dependent calcium channel gamma-2 subunit | Mus musculus (house mouse) | Potency | 25.8678 | 1 | 15 |
| Vpr | Human immunodeficiency virus 1 | Potency | 23.5929 | 1 | 4 |
| WRN | Homo sapiens (human) | Potency | 23.3659 | 1 | 3 |
| Protein | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Drugs |
|---|
| 3-oxo-5-alpha-steroid 4-dehydrogenase 1 | Rattus norvegicus (Norway rat) | IC50 | 12.2000 | 1 | 1 |
| 3-oxo-5-alpha-steroid 4-dehydrogenase 2 | Rattus norvegicus (Norway rat) | IC50 | 12.2000 | 1 | 1 |
| 3-oxoacyl-[acyl-carrier-protein] synthase 3 | Escherichia coli | IC50 | 925.0000 | 1 | 2 |
| 4-aminobutyrate aminotransferase, mitochondrial | Rattus norvegicus (Norway rat) | IC50 | 1.7500 | 1 | 4 |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | IC50 | 0.3500 | 1 | 1 |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | Ki | 155.0000 | 1 | 1 |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | IC50 | 0.3500 | 1 | 1 |
| 5-hydroxytryptamine receptor 1D | Rattus norvegicus (Norway rat) | IC50 | 0.3500 | 1 | 1 |
| 5-hydroxytryptamine receptor 1F | Rattus norvegicus (Norway rat) | IC50 | 0.3500 | 1 | 1 |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | IC50 | 5.6375 | 3 | 4 |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | Ki | 0.0803 | 2 | 2 |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | Ki | 0.3000 | 2 | 2 |
| 5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | IC50 | 65.2000 | 4 | 4 |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | Ki | 10.0000 | 1 | 1 |
| 5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | Ki | 0.3000 | 2 | 2 |
| 5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | IC50 | 0.3500 | 1 | 1 |
| 5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | Ki | 0.3000 | 2 | 2 |
| 5-hydroxytryptamine receptor 3A | Rattus norvegicus (Norway rat) | IC50 | 0.3500 | 1 | 1 |
| 5-hydroxytryptamine receptor 3B | Rattus norvegicus (Norway rat) | IC50 | 0.3500 | 1 | 1 |
| 5-hydroxytryptamine receptor 4 | Rattus norvegicus (Norway rat) | IC50 | 0.3500 | 1 | 1 |
| 5-hydroxytryptamine receptor 5A | Rattus norvegicus (Norway rat) | IC50 | 0.3500 | 1 | 1 |
| 5-hydroxytryptamine receptor 5B | Rattus norvegicus (Norway rat) | IC50 | 0.3500 | 1 | 1 |
| 5-hydroxytryptamine receptor 6 | Homo sapiens (human) | IC50 | 1.3390 | 1 | 1 |
| 5-hydroxytryptamine receptor 6 | Rattus norvegicus (Norway rat) | IC50 | 0.3500 | 1 | 1 |
| 5-hydroxytryptamine receptor 6 | Homo sapiens (human) | Ki | 0.6220 | 1 | 1 |
| 5-hydroxytryptamine receptor 7 | Cavia porcellus (domestic guinea pig) | IC50 | 63.8500 | 1 | 8 |
| 5-hydroxytryptamine receptor 7 | Rattus norvegicus (Norway rat) | IC50 | 0.3500 | 1 | 1 |
| Acetylcholinesterase | Homo sapiens (human) | IC50 | 190.1750 | 1 | 2 |
| Acetylcholinesterase | Electrophorus electricus (electric eel) | Ki | 109.0000 | 1 | 1 |
| Acetylcholinesterase | Mus musculus (house mouse) | Ki | 21.0000 | 1 | 1 |
| Acid-sensing ion channel 1 | Rattus norvegicus (Norway rat) | IC50 | 288.0192 | 5 | 9 |
| Acid-sensing ion channel 3 | Rattus norvegicus (Norway rat) | IC50 | 512.8610 | 1 | 1 |
| Acyl-CoA desaturase 1 | Rattus norvegicus (Norway rat) | Ki | 0.2990 | 1 | 1 |
| Adenosine receptor A1 | Rattus norvegicus (Norway rat) | IC50 | 2,348.3333 | 1 | 3 |
| Adenosine receptor A2a | Rattus norvegicus (Norway rat) | IC50 | 2,348.3333 | 1 | 3 |
| Albumin | Bos taurus (cattle) | IC50 | 3.0000 | 1 | 1 |
| Albumin | Homo sapiens (human) | Ki | 235,340,000,000.0000 | 1 | 3 |
| Aldo-keto reductase family 1 member B1 | Bos taurus (cattle) | IC50 | 100.0000 | 1 | 1 |
| Aldo-keto reductase family 1 member B1 | Homo sapiens (human) | IC50 | 140.0000 | 2 | 2 |
| Aldo-keto reductase family 1 member B10 | Homo sapiens (human) | IC50 | 1.9000 | 1 | 1 |
| Aldo-keto reductase family 1 member C1 | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| Aldo-keto reductase family 1 member C2 | Homo sapiens (human) | IC50 | 16.2800 | 2 | 2 |
| Aldo-keto reductase family 1 member C3 | Homo sapiens (human) | IC50 | 8.9520 | 4 | 5 |
| Aldo-keto reductase family 1 member C4 | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| Alkaline phosphatase, germ cell type | Homo sapiens (human) | IC50 | 12,840.0000 | 2 | 2 |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 0.0002 | 1 | 1 |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | IC50 | 0.0034 | 1 | 1 |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | IC50 | 0.0002 | 1 | 1 |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | IC50 | 0.0002 | 1 | 1 |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | IC50 | 0.0002 | 1 | 1 |
| Alpha-glucosidase MAL12 | Saccharomyces cerevisiae S288C | IC50 | 300.0000 | 1 | 1 |
| AmpC | Escherichia coli | IC50 | 0.0600 | 1 | 1 |
| Amyloid-beta precursor protein | Homo sapiens (human) | IC50 | 4.7000 | 2 | 2 |
| Androgen receptor | Rattus norvegicus (Norway rat) | IC50 | 1.1725 | 2 | 2 |
| Androgen receptor | Rattus norvegicus (Norway rat) | Ki | 1.0900 | 1 | 1 |
| Angiotensin-converting enzyme | Oryctolagus cuniculus (rabbit) | IC50 | 27.8497 | 1 | 1 |
| Angiotensin-converting enzyme | Oryctolagus cuniculus (rabbit) | Ki | 22.8166 | 1 | 1 |
| ATP-binding cassette sub-family C member 3 | Homo sapiens (human) | IC50 | 128.8684 | 1 | 19 |
| ATP-dependent 6-phosphofructokinase | Trypanosoma brucei brucei | IC50 | 57.0000 | 1 | 1 |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | IC50 | 139.5400 | 12 | 15 |
| ATP-dependent translocase ABCB1 | Mus musculus (house mouse) | IC50 | 30.7500 | 4 | 8 |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | Ki | 3.6240 | 5 | 5 |
| Aurora kinase A | Homo sapiens (human) | IC50 | 21.0000 | 1 | 1 |
| bcl-2-related protein A1 | Mus musculus (house mouse) | IC50 | 100.0000 | 2 | 2 |
| Beta lactamase (plasmid) | Pseudomonas aeruginosa | IC50 | 17.5950 | 2 | 2 |
| Beta-2 adrenergic receptor | Cavia porcellus (domestic guinea pig) | IC50 | 0.2500 | 1 | 1 |
| Beta-carbonic anhydrase 1 | Mycobacterium tuberculosis H37Rv | Ki | 12.1857 | 5 | 7 |
| Beta-lactamase | Escherichia coli | IC50 | 0.0320 | 1 | 1 |
| Beta-lactamase | Klebsiella pneumoniae | IC50 | 1,000.0030 | 2 | 2 |
| Beta-lactamase | Acinetobacter baumannii | Ki | 1.5018 | 2 | 4 |
| Beta-lactamase | Citrobacter freundii | Ki | 2.0000 | 1 | 1 |
| Beta-lactamase TEM | Escherichia coli | Ki | 20.0000 | 1 | 1 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | Cryptosporidium parvum | IC50 | 14.0000 | 1 | 1 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | Leishmania major | IC50 | 20.5000 | 1 | 1 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | Plasmodium berghei ANKA | IC50 | 0.1350 | 5 | 6 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | Plasmodium falciparum K1 | IC50 | 68.2550 | 2 | 2 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | Toxoplasma gondii | IC50 | 80.5069 | 46 | 59 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | Leishmania major | Ki | 0.1200 | 1 | 1 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | Plasmodium falciparum K1 | Ki | 2.7038 | 7 | 11 |
| Bile salt export pump | Homo sapiens (human) | IC50 | 388.1044 | 5 | 64 |
| Bile salt export pump | Rattus norvegicus (Norway rat) | IC50 | 822.7250 | 1 | 4 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | IC50 | 385.0000 | 1 | 1 |
| C-X-C chemokine receptor type 1 | Homo sapiens (human) | IC50 | 5.0060 | 2 | 2 |
| Calcium/calmodulin-dependent protein kinase type II subunit alpha | Rattus norvegicus (Norway rat) | Ki | 5.1000 | 1 | 1 |
| Canalicular multispecific organic anion transporter 1 | Homo sapiens (human) | IC50 | 130.7053 | 1 | 19 |
| Carbonic anhydrase | Candida albicans SC5314 | Ki | 9.2793 | 5 | 6 |
| Carbonic anhydrase | Helicobacter pylori 26695 | Ki | 0.4425 | 2 | 2 |
| Carbonic anhydrase | Methanosarcina thermophila | Ki | 2.0900 | 2 | 2 |
| Carbonic anhydrase | Methanothermobacter thermautotrophicus str. Delta H | Ki | 57.8000 | 1 | 1 |
| Carbonic anhydrase | Saccharomyces cerevisiae S288C | Ki | 18.5000 | 1 | 1 |
| Carbonic anhydrase | Stylophora pistillata | Ki | 0.3000 | 1 | 1 |
| Carbonic anhydrase | Anopheles gambiae (African malaria mosquito) | Ki | 0.8620 | 1 | 1 |
| Carbonic anhydrase | Astrosclera willeyana | Ki | 7.7000 | 1 | 1 |
| Carbonic anhydrase | Cryptococcus neoformans var. grubii | Ki | 0.7675 | 2 | 2 |
| Carbonic anhydrase | Mycobacterium tuberculosis H37Rv | Ki | 6.6750 | 2 | 2 |
| Carbonic anhydrase | Nakaseomyces glabratus CBS 138 | Ki | 8.0110 | 1 | 1 |
| Carbonic anhydrase | Stylophora pistillata | Ki | 0.3640 | 2 | 2 |
| Carbonic anhydrase | Sulfurihydrogenibium sp. YO3AOP1 | Ki | 0.6520 | 1 | 1 |
| Carbonic anhydrase 1 | Homo sapiens (human) | IC50 | 453.8916 | 5 | 18 |
| Carbonic anhydrase 1 | Homo sapiens (human) | Ki | 585,276,149.1600 | 77 | 96 |
| Carbonic anhydrase 12 | Homo sapiens (human) | Ki | 3.6746 | 14 | 14 |
| Carbonic anhydrase 13 | Homo sapiens (human) | Ki | 0.0335 | 2 | 2 |
| Carbonic anhydrase 13 | Mus musculus (house mouse) | Ki | 0.0320 | 2 | 2 |
| Carbonic anhydrase 14 | Homo sapiens (human) | Ki | 5.4000 | 4 | 4 |
| Carbonic anhydrase 15 | Mus musculus (house mouse) | Ki | 7.4428 | 3 | 4 |
| Carbonic anhydrase 2 | Homo sapiens (human) | IC50 | 301.3848 | 9 | 22 |
| Carbonic anhydrase 2 | Bos taurus (cattle) | Ki | 12.9850 | 1 | 2 |
| Carbonic anhydrase 2 | Homo sapiens (human) | Ki | 160.1542 | 90 | 112 |
| Carbonic anhydrase 2 | Mycobacterium tuberculosis H37Rv | Ki | 19.0375 | 2 | 4 |
| Carbonic anhydrase 3 | Bos taurus (cattle) | Ki | 32.8520 | 1 | 4 |
| Carbonic anhydrase 3 | Homo sapiens (human) | Ki | 362.9960 | 3 | 3 |
| Carbonic anhydrase 4 | Bos taurus (cattle) | IC50 | 100.0000 | 2 | 4 |
| Carbonic anhydrase 4 | Bos taurus (cattle) | Ki | 315,773,689.0134 | 13 | 19 |
| Carbonic anhydrase 4 | Homo sapiens (human) | Ki | 21.3960 | 5 | 5 |
| Carbonic anhydrase 5A, mitochondrial | Homo sapiens (human) | IC50 | 32.0000 | 1 | 1 |
| Carbonic anhydrase 5A, mitochondrial | Homo sapiens (human) | Ki | 1,020.2700 | 5 | 7 |
| Carbonic anhydrase 5A, mitochondrial | Mus musculus (house mouse) | Ki | 8.1650 | 1 | 4 |
| Carbonic anhydrase 5B, mitochondrial | Homo sapiens (human) | Ki | 8.6380 | 3 | 5 |
| Carbonic anhydrase 6 | Homo sapiens (human) | IC50 | 14.1166 | 1 | 9 |
| Carbonic anhydrase 6 | Homo sapiens (human) | Ki | 13.6697 | 8 | 14 |
| Carbonic anhydrase 7 | Homo sapiens (human) | Ki | 0.0700 | 3 | 3 |
| Carbonic anhydrase 9 | Homo sapiens (human) | IC50 | 42.5176 | 5 | 5 |
| Carbonic anhydrase 9 | Homo sapiens (human) | Ki | 4,851.3902 | 27 | 31 |
| Carbonic anhydrase, alpha family | Hydrogenovibrio crunogenus XCL-2 | Ki | 0.6280 | 1 | 1 |
| Carbonyl reductase [NADPH] 1 | Homo sapiens (human) | IC50 | 0.4000 | 1 | 1 |
| Carbonyl reductase [NADPH] 1 | Homo sapiens (human) | Ki | 0.0600 | 1 | 1 |
| carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 | Homo sapiens (human) | IC50 | 7.1840 | 1 | 1 |
| caspase recruitment domain family, member 15 | Homo sapiens (human) | IC50 | 1.4020 | 1 | 1 |
| Caspase-1 | Homo sapiens (human) | IC50 | 20.5630 | 1 | 20 |
| Caspase-3 | Homo sapiens (human) | IC50 | 22.9427 | 3 | 22 |
| Caspase-4 | Homo sapiens (human) | IC50 | 20.5630 | 1 | 20 |
| Caspase-5 | Homo sapiens (human) | IC50 | 20.5630 | 1 | 20 |
| Caspase-7 | Homo sapiens (human) | IC50 | 137.4000 | 1 | 1 |
| Caspase-9 | Homo sapiens (human) | IC50 | 20.5630 | 1 | 20 |
| Chain A, Dihydrofolate reductase | Bacillus anthracis | IC50 | 77,200.0000 | 1 | 1 |
| Chain A, Dihydrofolate reductase | Homo sapiens (human) | Ki | 0.6050 | 1 | 4 |
| Chain A, dihydrofolate reductase (DHFR) | Bacillus anthracis | IC50 | 77,200.0000 | 1 | 1 |
| Chain A, enoyl-acyl carrier reductase | Plasmodium falciparum (malaria parasite P. falciparum) | Ki | 0.0500 | 1 | 3 |
| Chain A, Histamine N-methyltransferase | Homo sapiens (human) | Ki | 0.0186 | 1 | 4 |
| Chain A, Oxygen-insensitive Nad(p)h Nitroreductase | Enterobacter cloacae | Ki | 100.0000 | 1 | 1 |
| Chain B, Oxygen-insensitive Nad(p)h Nitroreductase | Enterobacter cloacae | Ki | 100.0000 | 1 | 1 |
| Chain C, enoyl-acyl carrier reductase | Plasmodium falciparum (malaria parasite P. falciparum) | Ki | 0.0500 | 1 | 3 |
| Cholinesterase | Equus caballus (horse) | IC50 | 7.3700 | 1 | 1 |
| Cholinesterase | Homo sapiens (human) | IC50 | 246.6733 | 2 | 3 |
| corticotropin releasing factor-binding protein | Homo sapiens (human) | IC50 | 47.1000 | 1 | 1 |
| corticotropin-releasing hormone receptor 2 | Homo sapiens (human) | IC50 | 47.1000 | 1 | 1 |
| Cystathionine gamma-lyase | Homo sapiens (human) | IC50 | 270.0000 | 1 | 1 |
| cysteine protease ATG4B isoform a | Homo sapiens (human) | IC50 | 11.0000 | 1 | 1 |
| Cystine/glutamate transporter | Homo sapiens (human) | IC50 | 1,000.0000 | 1 | 1 |
| Cytochrome c oxidase subunit 2 | Homo sapiens (human) | IC50 | 10.0500 | 1 | 1 |
| Cytochrome P450 1A2 | Homo sapiens (human) | Ki | 56.0000 | 1 | 1 |
| Cytochrome P450 2A6 | Homo sapiens (human) | Ki | 60.0000 | 1 | 1 |
| Cytochrome P450 2C19 | Homo sapiens (human) | Ki | 10.0000 | 1 | 1 |
| Cytochrome P450 2C8 | Homo sapiens (human) | Ki | 374.0000 | 1 | 1 |
| Cytochrome P450 2C9 | Homo sapiens (human) | IC50 | 42.0433 | 1 | 9 |
| Cytochrome P450 2C9 | Homo sapiens (human) | Ki | 24.4500 | 4 | 6 |
| Cytochrome P450 2D1 | Rattus norvegicus (Norway rat) | IC50 | 669.9500 | 1 | 2 |
| Cytochrome P450 2D26 | Rattus norvegicus (Norway rat) | IC50 | 120.4000 | 1 | 2 |
| Cytochrome P450 2D3 | Rattus norvegicus (Norway rat) | IC50 | 2,057.9500 | 1 | 2 |
| Cytochrome P450 2D4 | Rattus norvegicus (Norway rat) | IC50 | 1,131.6000 | 1 | 2 |
| Cytochrome P450 2D6 | Homo sapiens (human) | IC50 | 10.5351 | 45 | 48 |
| Cytochrome P450 2D6 | Homo sapiens (human) | Ki | 0.0357 | 4 | 4 |
| Cytochrome P450 2J2 | Homo sapiens (human) | IC50 | 42.0433 | 1 | 9 |
| Cytochrome P450 3A4 | Homo sapiens (human) | IC50 | 240.9008 | 3 | 4 |
| Cytochrome P450 3A4 | Homo sapiens (human) | Ki | 1,239.0000 | 2 | 4 |
| D-amino-acid oxidase | Homo sapiens (human) | IC50 | 51.7379 | 5 | 5 |
| D-amino-acid oxidase | Homo sapiens (human) | Ki | 22.2800 | 5 | 5 |
| D-aspartate oxidase | Homo sapiens (human) | IC50 | 10,000.0000 | 2 | 2 |
| Dehydrogenase/reductase SDR family member 9 | Rattus norvegicus (Norway rat) | IC50 | 100.0000 | 1 | 1 |
| Delta carbonic anhydrase | Conticribra weissflogii | Ki | 0.1810 | 1 | 1 |
| Delta-type opioid receptor | Homo sapiens (human) | IC50 | 1.6499 | 5 | 6 |
| Delta-type opioid receptor | Mus musculus (house mouse) | IC50 | 2.5881 | 6 | 13 |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | IC50 | 0.2278 | 11 | 16 |
| Delta-type opioid receptor | Homo sapiens (human) | Ki | 1.7127 | 28 | 36 |
| Delta-type opioid receptor | Mus musculus (house mouse) | Ki | 12.6200 | 2 | 2 |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | Ki | 0.1737 | 14 | 16 |
| Dihydrofolate reductase | Candida albicans | IC50 | 24.5144 | 5 | 5 |
| Dihydrofolate reductase | Escherichia coli K-12 | IC50 | 248.7591 | 32 | 48 |
| Dihydrofolate reductase | Gallus gallus (chicken) | IC50 | 445.0000 | 3 | 4 |
| Dihydrofolate reductase | Homo sapiens (human) | IC50 | 202.0566 | 44 | 63 |
| Dihydrofolate reductase | Lacticaseibacillus casei | IC50 | 0.3492 | 4 | 4 |
| Dihydrofolate reductase | Lactococcus lactis subsp. lactis Il1403 | IC50 | 0.4500 | 1 | 1 |
| Dihydrofolate reductase | Mycobacterium tuberculosis H37Rv | IC50 | 88.0000 | 1 | 1 |
| Dihydrofolate reductase | Neisseria gonorrhoeae | IC50 | 0.4900 | 2 | 4 |
| Dihydrofolate reductase | Pneumocystis carinii | IC50 | 262.5425 | 41 | 53 |
| Dihydrofolate reductase | Rattus norvegicus (Norway rat) | IC50 | 3,104.8889 | 48 | 61 |
| Dihydrofolate reductase | Saccharomyces cerevisiae S288C | IC50 | 12.0000 | 1 | 1 |
| Dihydrofolate reductase | Staphylococcus aureus | IC50 | 982.6437 | 10 | 17 |
| Dihydrofolate reductase | Streptococcus pneumoniae TIGR4 | IC50 | 64.1815 | 2 | 6 |
| Dihydrofolate reductase | Escherichia coli K-12 | Ki | 0.0036 | 8 | 9 |
| Dihydrofolate reductase | Gallus gallus (chicken) | Ki | 81.3666 | 2 | 3 |
| Dihydrofolate reductase | Homo sapiens (human) | Ki | 523.9692 | 13 | 15 |
| Dihydrofolate reductase | Lacticaseibacillus casei | Ki | 0.1260 | 1 | 2 |
| Dihydrofolate reductase | Mus musculus (house mouse) | Ki | 0.5000 | 1 | 1 |
| Dihydrofolate reductase | Mycobacterium tuberculosis H37Rv | Ki | 0.0010 | 1 | 1 |
| Dihydrofolate reductase | Pneumocystis carinii | Ki | 93.4345 | 3 | 3 |
| Dihydrofolate reductase | Staphylococcus aureus | Ki | 0.2115 | 13 | 13 |
| Dihydrofolate reductase | Bacillus anthracis | IC50 | 45.7880 | 5 | 5 |
| Dihydrofolate reductase | Bos taurus (cattle) | IC50 | 3,204.7850 | 2 | 2 |
| Dihydrofolate reductase | Mycobacterium avium | IC50 | 33.5633 | 9 | 9 |
| Dihydrofolate reductase | Pneumocystis jirovecii | IC50 | 0.0920 | 1 | 1 |
| Dihydrofolate reductase | Bacillus anthracis | Ki | 12.7600 | 3 | 3 |
| Dihydrofolate reductase | Salmonella enterica subsp. enterica serovar Typhi | Ki | 0.0137 | 1 | 2 |
| Dihydrofolate reductase type 1 | Escherichia coli | IC50 | 0.2500 | 2 | 2 |
| Dihydrofolate reductase type 1 from Tn4003 | Staphylococcus aureus | IC50 | 109.5308 | 1 | 4 |
| Dihydropteroate synthase | Escherichia coli K-12 | IC50 | 3.6000 | 1 | 2 |
| Dipeptidyl peptidase 4 | Homo sapiens (human) | IC50 | 2.7000 | 3 | 3 |
| Dipeptidyl peptidase 4 | Rattus norvegicus (Norway rat) | IC50 | 2.7000 | 1 | 1 |
| DNA gyrase subunit A | Escherichia coli K-12 | IC50 | 1,000.0000 | 1 | 2 |
| DNA gyrase subunit A | Mycobacterium tuberculosis H37Rv | IC50 | 50.0000 | 1 | 1 |
| DNA gyrase subunit B | Escherichia coli K-12 | IC50 | 1,000.0000 | 1 | 2 |
| DNA gyrase subunit B | Mycobacterium tuberculosis H37Rv | IC50 | 50.0000 | 1 | 1 |
| Efflux transporter | Salmonella enterica subsp. enterica serovar Newport | IC50 | 0.0060 | 1 | 1 |
| Endonuclease 8-like 1 | Homo sapiens (human) | IC50 | 50.0000 | 1 | 1 |
| Endonuclease III-like protein 1 | Homo sapiens (human) | IC50 | 50.0000 | 1 | 1 |
| Endoplasmic reticulum chaperone BiP | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| Endothelin-1 receptor | Homo sapiens (human) | IC50 | 23.1100 | 3 | 4 |
| Endothelin-1 receptor | Rattus norvegicus (Norway rat) | IC50 | 124.7967 | 3 | 6 |
| Endothelin-1 receptor | Homo sapiens (human) | Ki | 13.4650 | 1 | 1 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | Mycobacterium tuberculosis H37Rv | IC50 | 3.4733 | 8 | 9 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | Mycobacterium tuberculosis H37Rv | Ki | 0.2100 | 4 | 4 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | Francisella tularensis subsp. tularensis SCHU S4 | IC50 | 4.3300 | 5 | 5 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] FabI | Bacillus subtilis subsp. subtilis str. 168 | IC50 | 0.5000 | 1 | 1 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] FabI | Escherichia coli K-12 | IC50 | 2.9579 | 8 | 12 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] FabI | Haemophilus influenzae Rd KW20 | IC50 | 7.6425 | 2 | 4 |
| Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI | Staphylococcus aureus subsp. aureus MRSA252 | IC50 | 2.6049 | 10 | 14 |
| Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI | Staphylococcus aureus subsp. aureus MRSA252 | Ki | 0.0000 | 1 | 1 |
| Enoyl-ACP reductase II | Streptococcus pneumoniae | IC50 | 32.0000 | 2 | 2 |
| Enoyl-acyl carrier reductase | Toxoplasma gondii | IC50 | 0.0167 | 3 | 3 |
| Enoyl-acyl-carrier protein reductase | Plasmodium falciparum (malaria parasite P. falciparum) | IC50 | 0.0872 | 8 | 8 |
| Enoyl-acyl-carrier protein reductase | Plasmodium falciparum (malaria parasite P. falciparum) | Ki | 0.0554 | 17 | 17 |
| Epidermal growth factor receptor | Homo sapiens (human) | IC50 | 10.0000 | 1 | 3 |
| Estrogen receptor | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| Estrogen receptor beta | Homo sapiens (human) | IC50 | 10.0000 | 1 | 1 |
| exodeoxyribonuclease V subunit RecB | Escherichia coli str. K-12 substr. MG1655 | IC50 | 87.8796 | 2 | 5 |
| exodeoxyribonuclease V subunit RecC | Escherichia coli str. K-12 substr. MG1655 | IC50 | 87.8796 | 2 | 5 |
| exodeoxyribonuclease V subunit RecD | Escherichia coli str. K-12 substr. MG1655 | IC50 | 87.8796 | 2 | 5 |
| fatty acid synthase | Homo sapiens (human) | IC50 | 3.5350 | 2 | 2 |
| Fatty acid-binding protein, intestinal | Homo sapiens (human) | Ki | 144.0667 | 1 | 3 |
| Fatty acid-binding protein, liver | Rattus norvegicus (Norway rat) | Ki | 777.0367 | 2 | 6 |
| Fatty-acid amide hydrolase 1 | Rattus norvegicus (Norway rat) | IC50 | 575.5000 | 3 | 4 |
| Formamidopyrimidine-DNA glycosylase | Escherichia coli K-12 | IC50 | 50.0000 | 1 | 1 |
| GABA theta subunit | Rattus norvegicus (Norway rat) | IC50 | 29.5000 | 1 | 1 |
| GABA theta subunit | Rattus norvegicus (Norway rat) | Ki | 100.0000 | 1 | 1 |
| Gamma-aminobutyric acid | Mus musculus (house mouse) | Ki | 155.0000 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | IC50 | 14.9250 | 2 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Homo sapiens (human) | Ki | 100.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Mus musculus (house mouse) | Ki | 155.0000 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | Ki | 100.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | IC50 | 29.5000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Homo sapiens (human) | Ki | 100.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Mus musculus (house mouse) | Ki | 155.0000 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | Ki | 100.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | IC50 | 29.5000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Homo sapiens (human) | Ki | 100.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Mus musculus (house mouse) | Ki | 155.0000 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | Ki | 100.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | IC50 | 29.5000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Homo sapiens (human) | Ki | 100.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Mus musculus (house mouse) | Ki | 155.0000 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | Ki | 100.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Rattus norvegicus (Norway rat) | IC50 | 29.5000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Homo sapiens (human) | Ki | 100.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Mus musculus (house mouse) | Ki | 155.0000 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Rattus norvegicus (Norway rat) | Ki | 100.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Rattus norvegicus (Norway rat) | IC50 | 29.5000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Homo sapiens (human) | Ki | 100.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Mus musculus (house mouse) | Ki | 155.0000 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Rattus norvegicus (Norway rat) | Ki | 100.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Rattus norvegicus (Norway rat) | IC50 | 29.5000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Homo sapiens (human) | Ki | 100.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Mus musculus (house mouse) | Ki | 155.0000 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit beta-1 | Rattus norvegicus (Norway rat) | Ki | 100.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-2 | Rattus norvegicus (Norway rat) | IC50 | 29.5000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-2 | Homo sapiens (human) | Ki | 100.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-2 | Rattus norvegicus (Norway rat) | Ki | 100.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Rattus norvegicus (Norway rat) | IC50 | 29.5000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Homo sapiens (human) | Ki | 100.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Mus musculus (house mouse) | Ki | 155.0000 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit beta-3 | Rattus norvegicus (Norway rat) | Ki | 100.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit delta | Rattus norvegicus (Norway rat) | IC50 | 29.5000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit delta | Homo sapiens (human) | Ki | 100.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit delta | Mus musculus (house mouse) | Ki | 155.0000 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit delta | Rattus norvegicus (Norway rat) | Ki | 100.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit epsilon | Rattus norvegicus (Norway rat) | IC50 | 29.5000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit epsilon | Homo sapiens (human) | Ki | 100.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit epsilon | Rattus norvegicus (Norway rat) | Ki | 100.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Rattus norvegicus (Norway rat) | IC50 | 29.5000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Homo sapiens (human) | Ki | 100.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Mus musculus (house mouse) | Ki | 155.0000 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Rattus norvegicus (Norway rat) | Ki | 100.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Rattus norvegicus (Norway rat) | IC50 | 29.5000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Homo sapiens (human) | Ki | 100.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Mus musculus (house mouse) | Ki | 155.0000 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Rattus norvegicus (Norway rat) | Ki | 100.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Rattus norvegicus (Norway rat) | IC50 | 29.5000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Homo sapiens (human) | Ki | 100.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Mus musculus (house mouse) | Ki | 155.0000 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Rattus norvegicus (Norway rat) | Ki | 100.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit pi | Rattus norvegicus (Norway rat) | IC50 | 29.5000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit pi | Homo sapiens (human) | Ki | 100.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit pi | Mus musculus (house mouse) | Ki | 155.0000 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit pi | Rattus norvegicus (Norway rat) | Ki | 100.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit theta | Homo sapiens (human) | Ki | 100.0000 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit theta | Mus musculus (house mouse) | Ki | 155.0000 | 1 | 3 |
| Glucocorticoid receptor | Homo sapiens (human) | IC50 | 0.0026 | 4 | 4 |
| Glucocorticoid receptor | Rattus norvegicus (Norway rat) | IC50 | 0.0029 | 1 | 1 |
| Glucocorticoid receptor | Homo sapiens (human) | Ki | 0.0017 | 2 | 2 |
| Glutathione hydrolase 1 proenzyme | Homo sapiens (human) | IC50 | 36.0000 | 1 | 1 |
| Glutathione peroxidase 1 | Homo sapiens (human) | Ki | 33.4000 | 1 | 2 |
| Glutathione reductase, mitochondrial | Homo sapiens (human) | Ki | 13.8800 | 1 | 2 |
| Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | IC50 | 0.0045 | 1 | 1 |
| Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | Ki | 0.0020 | 1 | 1 |
| Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | IC50 | 0.0045 | 1 | 1 |
| Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | Ki | 0.0020 | 1 | 1 |
| Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | IC50 | 0.0045 | 1 | 1 |
| Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | Ki | 0.0020 | 1 | 1 |
| Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | IC50 | 0.0045 | 1 | 1 |
| Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | Ki | 0.0020 | 1 | 1 |
| Histamine H1 receptor | Rattus norvegicus (Norway rat) | IC50 | 0.0008 | 1 | 2 |
| Histamine H2 receptor | Cavia porcellus (domestic guinea pig) | IC50 | 3.8000 | 1 | 1 |
| Histamine H3 receptor | Homo sapiens (human) | Ki | 5.0000 | 1 | 1 |
| Histamine H3 receptor | Rattus norvegicus (Norway rat) | Ki | 5.0000 | 1 | 1 |
| Histamine H4 receptor | Homo sapiens (human) | Ki | 10.0000 | 1 | 1 |
| Histidine-rich protein PFHRP-II | Plasmodium falciparum (malaria parasite P. falciparum) | IC50 | 325.0000 | 1 | 1 |
| Hormone-sensitive lipase | Rattus norvegicus (Norway rat) | IC50 | 1.2000 | 1 | 1 |
| integrase, partial | Human immunodeficiency virus 1 | IC50 | 1.8255 | 2 | 2 |
| Integrin alpha-IIb | Homo sapiens (human) | IC50 | 52.5000 | 2 | 2 |
| Integrin beta-3 | Homo sapiens (human) | IC50 | 52.5000 | 2 | 2 |
| Interleukin-5 | Homo sapiens (human) | IC50 | 26.8000 | 1 | 1 |
| Interleukin-5 | Mus musculus (house mouse) | IC50 | 26.5375 | 8 | 8 |
| Interleukin-5 receptor subunit alpha | Mus musculus (house mouse) | IC50 | 26.2000 | 1 | 1 |
| Interleukin-8 | Homo sapiens (human) | IC50 | 0.0080 | 1 | 1 |
| Isocitrate lyase | Mycobacterium tuberculosis H37Rv | IC50 | 455.8000 | 1 | 1 |
| Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | IC50 | 0.9308 | 5 | 6 |
| Kappa-type opioid receptor | Homo sapiens (human) | IC50 | 4.2413 | 3 | 4 |
| Kappa-type opioid receptor | Mus musculus (house mouse) | IC50 | 4.3330 | 2 | 7 |
| Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | IC50 | 0.0545 | 8 | 9 |
| Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | Ki | 4.6570 | 20 | 26 |
| Kappa-type opioid receptor | Homo sapiens (human) | Ki | 1.0469 | 26 | 27 |
| Kappa-type opioid receptor | Mus musculus (house mouse) | Ki | 0.9252 | 2 | 2 |
| Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | Ki | 0.1130 | 2 | 2 |
| Lactoylglutathione lyase | Homo sapiens (human) | Ki | 544.3500 | 3 | 6 |
| Large neutral amino acids transporter small subunit 1 | Rattus norvegicus (Norway rat) | Ki | 55.0000 | 1 | 1 |
| large T antigen | Betapolyomavirus macacae | IC50 | 32.5100 | 1 | 2 |
| lens epithelium-derived growth factor p75 | Homo sapiens (human) | IC50 | 1.8255 | 2 | 2 |
| Macrophage migration inhibitory factor | Homo sapiens (human) | IC50 | 400.0000 | 1 | 1 |
| Matrix metalloproteinase-9 | Homo sapiens (human) | IC50 | 1.9890 | 1 | 1 |
| Metabotropic glutamate receptor 5 | Rattus norvegicus (Norway rat) | IC50 | 2.7300 | 1 | 1 |
| Microsomal glutathione S-transferase 1 | Homo sapiens (human) | Ki | 33.9000 | 1 | 2 |
| Mineralocorticoid receptor | Homo sapiens (human) | IC50 | 0.0140 | 1 | 1 |
| Mitogen-activated protein kinase 1 | Homo sapiens (human) | IC50 | 0.8860 | 1 | 1 |
| Mitogen-activated protein kinase 14 | Homo sapiens (human) | IC50 | 2.1760 | 1 | 1 |
| Monoglyceride lipase | Rattus norvegicus (Norway rat) | IC50 | 0.3065 | 1 | 1 |
| MPI protein | Homo sapiens (human) | IC50 | 50.0000 | 1 | 1 |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | IC50 | 1.0847 | 6 | 6 |
| Mu-type opioid receptor | Homo sapiens (human) | IC50 | 0.1203 | 9 | 10 |
| Mu-type opioid receptor | Mus musculus (house mouse) | IC50 | 2.7478 | 7 | 12 |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | IC50 | 0.0385 | 11 | 13 |
| Mu-type opioid receptor | Bos taurus (cattle) | Ki | 0.0013 | 3 | 3 |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | Ki | 0.0492 | 16 | 25 |
| Mu-type opioid receptor | Danio rerio (zebrafish) | Ki | 0.1872 | 2 | 2 |
| Mu-type opioid receptor | Homo sapiens (human) | Ki | 0.2106 | 32 | 34 |
| Mu-type opioid receptor | Mus musculus (house mouse) | Ki | 0.0801 | 4 | 6 |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | Ki | 0.9367 | 17 | 27 |
| Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | IC50 | 255.1500 | 1 | 4 |
| Multidrug and toxin extrusion protein 2 | Homo sapiens (human) | IC50 | 55.5000 | 1 | 1 |
| Multidrug resistance-associated protein 4 | Homo sapiens (human) | IC50 | 116.8632 | 1 | 19 |
| Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | Ki | 0.0320 | 2 | 6 |
| Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | Ki | 0.0320 | 2 | 6 |
| Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | Ki | 0.0320 | 2 | 6 |
| Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | Ki | 0.0320 | 2 | 6 |
| Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | Ki | 0.0320 | 2 | 6 |
| Myeloperoxidase | Homo sapiens (human) | IC50 | 69.9000 | 3 | 3 |
| N-glycosylase/DNA lyase | Homo sapiens (human) | IC50 | 50.0000 | 4 | 4 |
| N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 | Homo sapiens (human) | IC50 | 13.2000 | 1 | 1 |
| Neuronal acetylcholine receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | Ki | 54.0000 | 1 | 1 |
| Neuronal acetylcholine receptor subunit beta-2 | Rattus norvegicus (Norway rat) | Ki | 54.0000 | 1 | 1 |
| NH(3)-dependent NAD(+) synthetase | Bacillus subtilis subsp. subtilis str. 168 | IC50 | 1.0000 | 1 | 1 |
| Nicotinate phosphoribosyltransferase | Homo sapiens (human) | Ki | 0.0012 | 1 | 2 |
| Nociceptin receptor | Cavia porcellus (domestic guinea pig) | Ki | 0.0025 | 1 | 1 |
| Nuclear receptor subfamily 3 group C member 3 | Bos taurus (cattle) | IC50 | 27.8497 | 1 | 1 |
| Nuclear receptor subfamily 3 group C member 3 | Bos taurus (cattle) | Ki | 22.8166 | 1 | 1 |
| Opioid receptor homologue | Danio rerio (zebrafish) | Ki | 0.2230 | 1 | 1 |
| Opioid receptor, delta 1b | Danio rerio (zebrafish) | Ki | 1.4270 | 1 | 1 |
| P2X purinoceptor 4 | Homo sapiens (human) | IC50 | 57.5000 | 1 | 4 |
| P2Y purinoceptor 12 | Rattus norvegicus (Norway rat) | IC50 | 0.0200 | 1 | 1 |
| Pantothenate synthetase | Mycobacterium tuberculosis H37Rv | IC50 | 25.0000 | 3 | 3 |
| Penicillin-binding protein 1A | Pseudomonas aeruginosa PAO1 | IC50 | 3.3400 | 1 | 1 |
| phospholipase A2 precursor | Homo sapiens (human) | IC50 | 15.2000 | 1 | 1 |
| Phospholipase C, beta 3 (phosphatidylinositol-specific) | Homo sapiens (human) | IC50 | 122.4810 | 1 | 1 |
| Phospholipase C, gamma 1 | Homo sapiens (human) | IC50 | 1.2120 | 1 | 1 |
| phosphomannomutase 2 | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| polyadenylate-binding protein 1 | Homo sapiens (human) | IC50 | 47.0500 | 2 | 2 |
| Polyphenol oxidase 2 | Agaricus bisporus | IC50 | 521.1017 | 6 | 6 |
| Polyunsaturated fatty acid 5-lipoxygenase | Homo sapiens (human) | IC50 | 0.5850 | 2 | 2 |
| Polyunsaturated fatty acid 5-lipoxygenase | Rattus norvegicus (Norway rat) | IC50 | 43.6667 | 2 | 3 |
| Potassium channel subfamily K member 18 | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
| Potassium channel subfamily K member 2 | Homo sapiens (human) | IC50 | 193.5000 | 2 | 2 |
| Potassium channel subfamily K member 3 | Homo sapiens (human) | IC50 | 465.5000 | 1 | 2 |
| Potassium voltage-gated channel subfamily A member 5 | Homo sapiens (human) | IC50 | 1,097.6500 | 1 | 2 |
| Potassium voltage-gated channel subfamily D member 2 | Rattus norvegicus (Norway rat) | IC50 | 606.1000 | 1 | 2 |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | IC50 | 445.3104 | 12 | 28 |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | Ki | 22.8166 | 1 | 1 |
| Progesterone receptor | Homo sapiens (human) | IC50 | 0.0280 | 1 | 1 |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | IC50 | 78.6394 | 33 | 45 |
| Prostaglandin G/H synthase 1 | Mus musculus (house mouse) | IC50 | 0.2200 | 1 | 1 |
| Prostaglandin G/H synthase 1 | Ovis aries (sheep) | IC50 | 653.0276 | 74 | 112 |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | Ki | 62.0000 | 1 | 1 |
| Prostaglandin G/H synthase 1 | Ovis aries (sheep) | Ki | 4.5800 | 2 | 2 |
| Prostaglandin G/H synthase 1 | Bos taurus (cattle) | IC50 | 1,014.6538 | 7 | 14 |
| Prostaglandin G/H synthase 1 | Rattus norvegicus (Norway rat) | IC50 | 0.7900 | 4 | 4 |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | IC50 | 260.2992 | 73 | 101 |
| Prostaglandin G/H synthase 2 | Mus musculus (house mouse) | IC50 | 0.1901 | 7 | 7 |
| Prostaglandin G/H synthase 2 | Ovis aries (sheep) | IC50 | 339.8186 | 29 | 42 |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | Ki | 52.0000 | 1 | 1 |
| Prostaglandin G/H synthase 2 | Ovis aries (sheep) | Ki | 9.0000 | 1 | 1 |
| Prostaglandin G/H synthase 2 | Bos taurus (cattle) | IC50 | 1,000.3667 | 2 | 3 |
| Prostaglandin G/H synthase 2 | Rattus norvegicus (Norway rat) | IC50 | 0.7900 | 4 | 4 |
| Prostaglandin-H2 D-isomerase | Mus musculus (house mouse) | IC50 | 1,500.0000 | 1 | 1 |
| Protease | Human immunodeficiency virus 1 | Ki | 0.0101 | 1 | 1 |
| Protein arginine N-methyltransferase 6 | Homo sapiens (human) | IC50 | 430.0000 | 1 | 1 |
| Protein-arginine deiminase type-4 | Homo sapiens (human) | IC50 | 9,166.6667 | 1 | 3 |
| Proteinase-activated receptor 1 | Homo sapiens (human) | Ki | 0.0022 | 1 | 1 |
| Putative FAD-containing monooxygenase MymA | Mycobacterium tuberculosis H37Rv | IC50 | 4.9000 | 1 | 1 |
| receptor-interacting serine/threonine-protein kinase 2 isoform 1 | Homo sapiens (human) | IC50 | 1.4020 | 1 | 1 |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | IC50 | 23.6120 | 2 | 5 |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | IC50 | 28.2275 | 1 | 4 |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | Ki | 2.4000 | 1 | 1 |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | Ki | 2.4000 | 1 | 1 |
| Reverse transcriptase/RNaseH | Human immunodeficiency virus 1 | IC50 | 0.1300 | 1 | 1 |
| Rho-associated protein kinase 2 | Rattus norvegicus (Norway rat) | IC50 | 100.0000 | 1 | 2 |
| Seed linoleate 13S-lipoxygenase-1 | Glycine max (soybean) | IC50 | 44.2500 | 2 | 3 |
| Serine racemase | Homo sapiens (human) | IC50 | 10,000.0000 | 1 | 1 |
| Serum paraoxonase/arylesterase 1 | Homo sapiens (human) | Ki | 13,010.0000 | 1 | 1 |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | Ki | 100.0000 | 1 | 1 |
| Sodium channel protein type 1 subunit alpha | Homo sapiens (human) | IC50 | 14.2500 | 1 | 2 |
| Sodium channel protein type 1 subunit alpha | Rattus norvegicus (Norway rat) | IC50 | 111.5000 | 1 | 4 |
| Sodium channel protein type 2 subunit alpha | Homo sapiens (human) | IC50 | 57.1250 | 3 | 4 |
| Sodium channel protein type 2 subunit alpha | Rattus norvegicus (Norway rat) | IC50 | 81.6667 | 3 | 6 |
| Sodium channel protein type 3 subunit alpha | Homo sapiens (human) | IC50 | 13.0000 | 2 | 3 |
| Sodium channel protein type 3 subunit alpha | Rattus norvegicus (Norway rat) | IC50 | 111.5000 | 1 | 4 |
| Sodium channel protein type 4 subunit alpha | Homo sapiens (human) | IC50 | 2.0000 | 1 | 1 |
| Sodium channel protein type 4 subunit alpha | Homo sapiens (human) | Ki | 38.0000 | 1 | 2 |
| Sodium channel protein type 5 subunit alpha | Homo sapiens (human) | IC50 | 47.0033 | 5 | 6 |
| Sodium channel protein type 9 subunit alpha | Homo sapiens (human) | IC50 | 50.3333 | 3 | 3 |
| Sodium channel protein type 9 subunit alpha | Homo sapiens (human) | Ki | 32.7000 | 1 | 1 |
| Sodium- and chloride-dependent betaine transporter | Rattus norvegicus (Norway rat) | IC50 | 15.0000 | 2 | 2 |
| Sodium- and chloride-dependent GABA transporter 1 | Rattus norvegicus (Norway rat) | IC50 | 15.0000 | 2 | 2 |
| Sodium- and chloride-dependent GABA transporter 2 | Rattus norvegicus (Norway rat) | IC50 | 15.0000 | 2 | 2 |
| Sodium- and chloride-dependent GABA transporter 3 | Rattus norvegicus (Norway rat) | IC50 | 15.0000 | 2 | 2 |
| Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | IC50 | 7.8000 | 1 | 1 |
| Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | Ki | 7.0000 | 2 | 2 |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | IC50 | 41.6000 | 5 | 5 |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | Ki | 0.7504 | 2 | 4 |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | IC50 | 0.0033 | 17 | 17 |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | Ki | 0.0380 | 15 | 16 |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | IC50 | 0.1961 | 4 | 4 |
| Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | IC50 | 23.5500 | 2 | 2 |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | Ki | 0.0200 | 1 | 1 |
| Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | Ki | 0.0824 | 2 | 2 |
| Solute carrier family 15 member 1 | Homo sapiens (human) | IC50 | 9,100.0000 | 2 | 2 |
| Solute carrier family 15 member 1 | Homo sapiens (human) | Ki | 19,487.3333 | 3 | 15 |
| Solute carrier family 15 member 1 | Rattus norvegicus (Norway rat) | Ki | 6,920.0000 | 1 | 1 |
| Solute carrier family 15 member 2 | Rattus norvegicus (Norway rat) | IC50 | 3,200.0000 | 1 | 1 |
| Solute carrier family 15 member 2 | Homo sapiens (human) | Ki | 9,233.4940 | 1 | 10 |
| Solute carrier family 15 member 2 | Rattus norvegicus (Norway rat) | Ki | 9,803.5556 | 2 | 9 |
| Solute carrier family 22 member 1 | Rattus norvegicus (Norway rat) | IC50 | 15.1000 | 1 | 2 |
| Solute carrier family 22 member 1 | Rattus norvegicus (Norway rat) | Ki | 7.8000 | 3 | 3 |
| Solute carrier family 22 member 1 | Homo sapiens (human) | IC50 | 71.7722 | 4 | 9 |
| Solute carrier family 22 member 1 | Homo sapiens (human) | Ki | 93.7150 | 2 | 4 |
| Solute carrier family 22 member 11 | Homo sapiens (human) | Ki | 4.2650 | 1 | 2 |
| Solute carrier family 22 member 2 | Homo sapiens (human) | IC50 | 78.8000 | 1 | 1 |
| Solute carrier family 22 member 2 | Rattus norvegicus (Norway rat) | IC50 | 12.3000 | 1 | 2 |
| Solute carrier family 22 member 2 | Homo sapiens (human) | Ki | 16.0000 | 1 | 1 |
| Solute carrier family 22 member 2 | Rattus norvegicus (Norway rat) | Ki | 19.1000 | 1 | 1 |
| Solute carrier family 22 member 20 | Mus musculus (house mouse) | Ki | 38.8591 | 1 | 6 |
| Solute carrier family 22 member 3 | Rattus norvegicus (Norway rat) | IC50 | 68.0000 | 1 | 1 |
| Solute carrier family 22 member 3 | Homo sapiens (human) | Ki | 14.0000 | 1 | 1 |
| Solute carrier family 22 member 4 | Rattus norvegicus (Norway rat) | IC50 | 80.0000 | 1 | 1 |
| Solute carrier family 22 member 6 | Homo sapiens (human) | IC50 | 4.1000 | 2 | 5 |
| Solute carrier family 22 member 6 | Rattus norvegicus (Norway rat) | IC50 | 946.8333 | 2 | 3 |
| Solute carrier family 22 member 6 | Homo sapiens (human) | Ki | 1.6800 | 1 | 2 |
| Solute carrier family 22 member 6 | Mus musculus (house mouse) | Ki | 315.3996 | 1 | 6 |
| Solute carrier family 22 member 6 | Rattus norvegicus (Norway rat) | Ki | 506.3000 | 3 | 5 |
| Solute carrier family 22 member 7 | Homo sapiens (human) | IC50 | 4,680.0000 | 1 | 1 |
| Solute carrier family 22 member 7 | Rattus norvegicus (Norway rat) | IC50 | 5,000.0000 | 1 | 1 |
| Solute carrier family 22 member 7 | Rattus norvegicus (Norway rat) | Ki | 1.8400 | 1 | 1 |
| Solute carrier family 22 member 8 | Homo sapiens (human) | IC50 | 120.0000 | 1 | 1 |
| Solute carrier family 22 member 8 | Mus musculus (house mouse) | IC50 | 89.4000 | 1 | 1 |
| Solute carrier family 22 member 8 | Rattus norvegicus (Norway rat) | IC50 | 1,400.0000 | 1 | 2 |
| Solute carrier family 22 member 8 | Homo sapiens (human) | Ki | 486.4560 | 2 | 5 |
| Solute carrier family 22 member 8 | Rattus norvegicus (Norway rat) | Ki | 52.8000 | 1 | 1 |
| Solute carrier organic anion transporter family member 1A1 | Rattus norvegicus (Norway rat) | Ki | 67.6350 | 1 | 2 |
| Solute carrier organic anion transporter family member 1A3 | Rattus norvegicus (Norway rat) | Ki | 1,900.0000 | 1 | 1 |
| Solute carrier organic anion transporter family member 1A4 | Rattus norvegicus (Norway rat) | Ki | 1,275.0000 | 1 | 2 |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | IC50 | 80.7000 | 1 | 1 |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | Ki | 37.4000 | 1 | 1 |
| Sporulation initiation phosphotransferase F | Bacillus subtilis subsp. subtilis str. 168 | IC50 | 42.3333 | 3 | 3 |
| Sporulation kinase A | Bacillus subtilis subsp. subtilis str. 168 | IC50 | 42.3333 | 3 | 3 |
| Substance-P receptor | Cavia porcellus (domestic guinea pig) | IC50 | 1.7500 | 1 | 2 |
| Succinyl-diaminopimelate desuccinylase | Haemophilus influenzae Rd KW20 | IC50 | 50.0000 | 1 | 1 |
| SUMO-1 | Homo sapiens (human) | IC50 | 34.0400 | 2 | 2 |
| Thromboxane-A synthase | Homo sapiens (human) | IC50 | 4.9270 | 1 | 1 |
| Thymidylate synthase | Escherichia coli K-12 | IC50 | 115.6033 | 2 | 6 |
| Thymidylate synthase | Homo sapiens (human) | IC50 | 115.6033 | 2 | 6 |
| Toll-like receptor 4 | Homo sapiens (human) | IC50 | 1.4000 | 1 | 1 |
| toll-like receptor 9 | Homo sapiens (human) | IC50 | 6.3390 | 1 | 1 |
| Transcriptional activator protein LasR | Pseudomonas aeruginosa PAO1 | IC50 | 9.0000 | 1 | 1 |
| Transporter | Rattus norvegicus (Norway rat) | IC50 | 10.6500 | 2 | 2 |
| Transporter | Rattus norvegicus (Norway rat) | Ki | 0.0074 | 2 | 3 |
| Transthyretin | Homo sapiens (human) | IC50 | 53.5000 | 1 | 1 |
| Tryptophan 5-hydroxylase 1 | Rattus norvegicus (Norway rat) | Ki | 0.0005 | 1 | 1 |
| Tyrosinase | Homo sapiens (human) | Ki | 520.0000 | 1 | 1 |
| Ubiquitin carboxyl-terminal hydrolase isozyme L5 | Homo sapiens (human) | IC50 | 2,946.0000 | 1 | 1 |
| UDP-glucuronosyltransferase 1-6 | Homo sapiens (human) | IC50 | 219.8750 | 1 | 8 |
| UDP-glucuronosyltransferase 1-6 | Homo sapiens (human) | Ki | 23.0000 | 1 | 1 |
| UDP-glucuronosyltransferase 1A1 | Homo sapiens (human) | IC50 | 219.8750 | 1 | 8 |
| UDP-glucuronosyltransferase 1A1 | Homo sapiens (human) | Ki | 52.0000 | 1 | 1 |
| UDP-glucuronosyltransferase 1A10 | Homo sapiens (human) | Ki | 28.0000 | 1 | 1 |
| UDP-glucuronosyltransferase 1A4 | Homo sapiens (human) | IC50 | 219.8750 | 1 | 8 |
| UDP-glucuronosyltransferase 1A7 | Homo sapiens (human) | Ki | 19.0000 | 1 | 1 |
| UDP-glucuronosyltransferase 1A9 | Homo sapiens (human) | Ki | 11.0000 | 1 | 1 |
| UDP-glucuronosyltransferase 2B10 | Homo sapiens (human) | IC50 | 219.8750 | 1 | 8 |
| UDP-glucuronosyltransferase 2B7 | Homo sapiens (human) | IC50 | 219.8750 | 1 | 8 |
| Uracil-DNA glycosylase | Vaccinia virus WR | IC50 | 38.5000 | 1 | 1 |
| Urotensin-2 receptor | Rattus norvegicus (Norway rat) | IC50 | 0.3000 | 1 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | Cavia porcellus (domestic guinea pig) | IC50 | 70.8000 | 2 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | Homo sapiens (human) | IC50 | 60.1533 | 6 | 6 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | Homo sapiens (human) | IC50 | 60.7000 | 3 | 3 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | Homo sapiens (human) | IC50 | 60.7000 | 3 | 3 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | Homo sapiens (human) | IC50 | 60.7000 | 3 | 3 |
| Voltage-dependent N-type calcium channel subunit alpha-1B | Homo sapiens (human) | IC50 | 11.0000 | 1 | 1 |